The Platform Group AG (ISIN DE000A2QEFA1, “TPG”), a leading software company for platform solutions, has acquired the fintus and finted AI business (through the acquisition of finone Holding), based ...
Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback